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Edited by: In order to maintain normal brain function, it is critical that cerebral blood flow (CBF) is
matched to neuronal metabolic needs. Accordingly, blood flow is increased to areas where
neurons are more active (a response termed functional hyperemia). The tight relationships
between neuronal activation, glial cell activity, cerebral energy metabolism, and the
cerebral vasculature, known as neurometabolic and neurovascular coupling, underpin
functional MRI (fMRI) signals but are incompletely understood. As functional imaging
techniques, particularly BOLD fMRI, become more widely used, their utility hinges on
our ability to accurately and reliably interpret the findings. A growing body of data
demonstrates that astrocytes can serve as a “bridge,” relaying information on the level
of neural activity to blood vessels in order to coordinate oxygen and glucose delivery with
the energy demands of the tissue. It is widely assumed that calcium-dependent release
of vasoactive substances by astrocytes results in arteriole dilation and the increased
blood flow which accompanies neuronal activity. However, the signaling molecules
responsible for this communication between astrocytes and blood vessels are yet to
be definitively confirmed. Indeed, there is controversy over whether activity-induced
changes in astrocyte calcium are widespread and fast enough to elicit such functional
hyperemia responses. In this review, I will summarize the evidence which has convincingly
demonstrated that astrocytes are able to modify the diameter of cerebral arterioles. I
will discuss the prevalence, presence, and timing of stimulus-induced astrocyte calcium
transients and describe the evidence for and against the role of calcium-dependent
formation and release of vasoactive substances by astrocytes. I will also review alternative
mechanisms of astrocyte-evoked changes in arteriole diameter and consider the questions
which remain to be answered in this exciting area of research.
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INTRODUCTION
For normal functioning of the brain to be maintained it is critical
that increases in neuronal energy demands are met by changes
in local blood flow with high temporal and spatial resolution.
This necessitates close connections between neurons, glia, and
the energy metabolism and blood supply of the brain. Increased
neuronal activity is accompanied by an increase in local cerebral
blood flow (CBF), a phenomenon termed functional hyperemia.
It is this increase in CBF and oxygenation which underlies BOLD
functional MRI (fMRI). BOLD fMRI is commonly used as a sur-
rogate measure of neural activity. A valid interpretation of such
data requires a thorough understanding of the cellular basis of
the BOLD signal. While a coupling between cerebral energy con-
sumption and neuronal activity was originally suggested over a
century ago (Roy and Sherrington, 1890), the exact relationship
remains an active area of research. Although neuronal activity
induced increases in blood flow are due, at least in part, to the
direct action of neurons [via glutamate-evoked release of nitric
oxide (NO)] on arteriole smooth muscle (Fergus and Lee, 1997),
over the past decade there has been extensive research (Zonta
et al., 2003; Mulligan and MacVicar, 2004; Filosa et al., 2006;
Takano et al., 2006) determining the role which astrocytes, and
activity-induced Ca2+ signals within astrocytes, may play (as
discussed in recent reviews by Attwell et al., 2010; Petzold and
Murthy, 2011).
Being situated in the synaptic cleft and having multiple endfeet
which are opposed to smooth muscle cells (Figure 1A), astro-
cytes can act as a “bridge,” relaying information about changes in
synaptic activity between neurons and the vasculature, ensuring
that neuronal energy demands are met.
INITIAL IN VITRO EVIDENCE DEMONSTRATED THAT
ASTROCYTES CAN REGULATE ARTERIOLE DIAMETER
Initial studies revealing a potential role of astrocytes in neurovas-
cular coupling were performed in vitro using acute brain slices
and whole mount retina. This in vitro research has resulted in
convincing evidence that astrocytes are able to control vascu-
lar diameter (Figure 1B). During neuronal activity, glutamate is
released and acts via neuronal NMDA receptors to activate neu-
ronal nitric oxide synthase (nNOS), resulting in the release of
NO. NO acts on smooth muscle cells, increasing blood flow via
a cGMP pathway (Fergus and Lee, 1997). However, in addition to
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FIGURE 1 | Increases in astrocyte [Ca2+]i are accompanied by changes in
vessel diameter in vitro and in vivo. (A) Two-dimensional projection of two
photon microscopy images showing that GFP-positive astrocytes and their
endfeet delineate an arteriole. Scale bar is 20 μm. Reprinted by permission from
Macmillan Publishers Ltd., Nature (Mulligan and MacVicar, 2004) copyright
(2004). (B) Astrocytes in brain slice from rat loaded with calcium indicator dye
(rhod-2/AM) and caged calcium compound (DMNPE-4/AM). Uncaging calcium
within astrocytes causes an increase in [Ca2+]i in astrocyte soma and endfeet
which preceded vasodilation (top). Vessel and pseudo-colored endfoot Ca2+
changes correspond to times in top image. Reprinted by permission from
Macmillan Publishers Ltd., Nature (Gordon et al., 2008) copyright (2008).
(C) Vessel diameter changes can be measured in mouse cortex in vivo using
2-photon microscopy in line scan mode. Here, calcium is measured using
rhod-2/AM and vessels are visualized with a dextran-coupled dye. Left, line scan
image of an artery exposed to photolysis of caged Ca2+ which increases
astrocyte [Ca2+]i. Astrocytic Ca2+ and vessel diameter increase almost
simultaneously following photolysis. Right, larger views of line scan section
indicated in yellow boxes. (D) Time course of changes in astrocyte [Ca2+]i and
vessel diameter in (C). Reprinted by permission from Macmillan Publishers
Ltd., Nature Neuroscience (Takano et al., 2006) copyright (2006).
triggering neuronal NO-evoked effects on the vasculature, neu-
ronally released glutamate can act on astrocyte metabotropic
glutamate receptors (mGluR), raising astrocyte [Ca2+]i (Zonta
et al., 2003; Takano et al., 2006). Over a decade ago, obser-
vations of astrocyte soma and endfeet [Ca2+]i signals which
were well-timed with vessel diameter changes in response to
mGluR activation were the first evidence that astrocytes may con-
tribute to neurovascular coupling (Zonta et al., 2003). This work
implicated cyclooxygenase enzymes (COX) in the downstream
signaling pathway leading from increased astrocyte [Ca2+]i to
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vessel dilation. An increase in astrocytic [Ca2+]i can result in
the production of arachidonic acid (AA) via phospholipase A2
(PLA2), a Ca2+ sensitive enzyme highly expressed in astro-
cytes (Farooqui et al., 1997; Cahoy et al., 2008). AA is subse-
quently metabolized to COX and cytochrome P450 epoxygenase
derivatives [prostaglandin E2 (PgE2) and epoxyeicosatrienoic
acids (EETs), respectively]. These vasoactive metabolites can be
released from the astrocyte endfeet, apposed to arterioles, result-
ing in activation of smooth muscle K+ channels and vasodilation
(although see Dabertrand et al. (2013) who suggest that PgE2 may
constrict, rather than dilate, isolated parenchymal arterioles).
In addition to AA being metabolized within the astrocyte,
it can diffuse to arteriole smooth muscle, producing the vaso-
constrictor 20-HETE via ω-hydroxylases (Roman, 2002). Shortly
after the demonstration that astrocyte [Ca2+]i increases were
closely linked to vasodilations, two photon photolysis of caged
calcium directly within the somata of astrocytes was used to
trigger a [Ca2+]i transient within the astrocyte and evoked
vasoconstriction (Mulligan and MacVicar, 2004). Pharmacology
experiments revealed the importance of PLA2 and it was pro-
posed that 20-HETE, a vasoconstrictor, was generated from
AA, which was formed in the astrocytes. 20-HETE inhibits
smooth muscle K+ conductances to depolarize and contract
smooth muscle cells (Lange et al., 1997). Thus, astrocyte
[Ca2+]i entry can trigger either vasodilation (Zonta et al.,
2003; Filosa et al., 2004) or vasoconstriction (Mulligan and
MacVicar, 2004) depending on which signaling pathway domi-
nates (Figure 2).
The retina is an ideal system in which to study blood flow regu-
lation in response to local signals as its low density of blood vessels
requires the ability to efficiently match the local blood supply
to local neuronal metabolic needs (Funk, 1997). The observa-
tion that glial [Ca2+]i transients were closely correlated in time
with changes in arteriole diameter was extended to the case of the
retina where both vasodilations and constrictions were reported
to be evoked by either physiological light stimulation or uncaging
of Ca2+ in Muller cells (Metea and Newman, 2006). In agree-
ment with the previous findings in hippocampal slices (Mulligan
and MacVicar, 2004), 20-HETE was implicated as the vasocon-
strictor molecule in the retina. However, in contrast to findings
in cortical slices (Zonta et al., 2003), the data suggested that
conversion of AA to EETs, rather than to PgE2, caused arteri-
ole dilations in the retina. The hunt was on to find the variable
which selects a dilatory response over a constrictive one and vice
versa.
While in vitro studies have several advantages, including the
ability to control various cellular elements, there are techni-
cal limitations to this approach which are worth noting. A
lack of myogenic tone, due to a lack of perfusion and intra-
luminal pressure (Iadecola and Nedergaard, 2007), can result
in vessels being maximally dilated. To compensate for this
loss of tone, in many studies, slices are pre-treated with a
vasoconstrictor (Zonta et al., 2003; Filosa et al., 2004; Metea
and Newman, 2006). However, preconstriction has been shown
to alter the direction of arteriolar responses (Mulligan and
MacVicar, 2004). Furthermore, many experiments are carried
out at non-physiological temperatures, e.g., with brain slices
FIGURE 2 | Astrocyte calcium-dependent vasoactive signaling
pathways. Neuronally released glutamate can act on astrocyte mGluRs,
activating PLC, and increasing astrocyte [Ca2+]i, activating PLA2 resulting in
the release of AA from the plasma membrane. AA can be metabolized
within the astrocyte to form PgE2 or EETs which are released and act on
smooth muscle cells, evoking vasodilation. Alternatively, AA can be
released and act on smooth muscle cells where it is metabolized to the
vasoconstrictor 20-HETE. ATP can activate Ca2+-mediated downstream
vasoactive pathways either by acting on P2Y receptors and activating PLC
or via P2X7 receptors, increasing [Ca2+]i. An alternative vasoactive pathway
downstream of the [Ca2+]i increase is the activation of BKCa channels and
subsequent efflux of the vasodilator K+.
maintained at room temperature (Mulligan and MacVicar, 2004;
Gordon et al., 2008).
HOW IS THE DIRECTION OF ARTERIOLE DIAMETER CHANGE
DETERMINED?
NO, which can bind to the heme moiety and inactivate
cytochrome P450 enzymes (Fleming, 2001; Roman, 2002), was
suggested to determine the direction of retinal arteriole diameter
change (Metea and Newman, 2006). While in the brain neu-
ral activity and the resulting NO production has been shown to
correspond to increases in blood flow (Akgoren et al., 1994), in
the retina the occurrence of vasoconstrictions dominated as NO
levels increased (Metea and Newman, 2006). This finding was
in agreement with pharmacological inhibition of NO synthase,
which converted astrocyte-evoked vasoconstrictions to vasodila-
tions in brain slices (Mulligan and MacVicar, 2004). A possible
explanation for this observation is that preconstriction of vessels
by L-NAME, which was used to inhibit NO synthase, increases the
basal tone of vessels and, hence, may predispose them to dilate to
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other factors (Blanco et al., 2008). Many of the enzymes suggested
to be responsible for signaling downstream of the increase of
astrocyte [Ca2+]i are sensitive to NO (e.g., CYP4A which pro-
duces 20-HETE) (Fleming, 2001; Roman, 2002) suggesting that a
complex relationship may exist between NO levels and neurovas-
cular coupling signaling pathways. Differing basal NO levels may
exist in different preparations, hence pathways may be inhibited
to varying degrees. This may explain why some groups reported
only constrictions (Mulligan and MacVicar, 2004) while others
reported constrictions and dilations (Metea and Newman, 2006).
Metabolic factors, such as partial pressure of oxygen (pO2)
(Offenhauser et al., 2005) and the extracellular lactate con-
centration (Hu and Wilson, 1997) change rapidly within the
parenchyma during neural activity. Gordon et al. (2008) per-
formed experiments in acute brain slices and proposed that such
metabolic factors may play a role in determining the direction
of arteriole diameter changes. The level of oxygen present in the
aCSF (artificial CSF) used in these experiments was found to
determine the direction of arteriole diameter change in response
to uncaging calcium within the soma of astrocytes (Gordon et al.,
2008). At higher levels of O2 (aCSF bubbled with 95% O2 and 5%
CO2, typical of acute brain slice experiments), vasoconstrictions
were triggered, while at lower O2 levels vasodilations dominated
(Figure 1B). The lower O2 level (aCSF bubbled with 20% O2),
resulted in a pO2 which mimics the lower end of physiological
measurements in vivo (Offenhauser et al., 2005). At the lower oxy-
gen levels used, both lactate and adenosine levels were increased
compared to under conditions of higher O2 and vasodilation
was proposed to be dominant due to two mechanisms. Firstly, as
uptake of PgE2 by the prostaglandin transporter is inhibited by
extracellular lactate (Chan et al., 2002), there is an accumulation
of extracellular PgE2 following [Ca2+]i-evoked PgE2 release by
astrocytes, thus facilitating the vasodilatory response. Secondly,
the increased levels of adenosine were proposed to be acting on
A2A receptors on the smooth muscle itself, blocking Ca2+ chan-
nels (Murphy et al., 2003) and preventing vasoconstriction. In
agreement with these findings, in ex vivo retina, the incidence of
light-evoked vasoconstrictions was lower in 21% O2 compared to
100% O2. Additionally, at the lower oxygen level, a PgE2 compo-
nent of vasodilation became salient (Mishra et al., 2011). Whether
such a mechanism plays a functional role in vivo remains to be
proven. Although changing tissue pO2 by breathing high or low
oxygen has been shown to change basal CBF and arteriole diam-
eter in the direction predicted by in vitro experiments (McCalden
et al., 1984; Mishra et al., 2011), hyperoxia had no effect on light-
evoked dilations or flow in the retina in vivo (Mishra et al., 2011).
Furthermore, an increased tissue pO2 failed to alter the func-
tional hyperemia response to sensory stimulation (Lindauer et al.,
2010). Lin et al. (2010) recently published human NMR spec-
troscopy studies showing that CBF increases were positively cor-
related with lactate production while being negatively correlated
with the percentage change in oxygen consumption (CMRO2).
These findings suggest that task-induced CBF responses are medi-
ated by factors other than the demand for oxygen. In order to test
the in vivo relevance of the findings of Gordon et al. (2008), it
may be more appropriate to test the end effectors predicted by
their experiments, i.e., lactate and adenosine.
ALTERNATIVE MECHANISMS OF ASTROCYTE CONTROL
OF CBF
In addition to the mGluR-evoked mechanisms of CBF regulation,
there is evidence for a further glutamate-dependent pathway. In
the olfactory bulb, intrinsic optical signal (IOS) changes (used as
a proxy for CBF measurements) in response to odor stimulation
were found to be unaffected by blocking AMPA/NMDA recep-
tors nor mGluRs (Gurden et al., 2006). However, the increase
in CBF was reduced when glial glutamate transporters were
blocked. This work was expanded by Schummers et al. (2008)
who demonstrated that, in visual cortex, the astrocytic [Ca2+]i
signal and the change in IOS in response to a visual stimu-
lus were significantly reduced when glial glutamate transporters
were blocked. Furthermore, blocking glial glutamate transporters
reduced odor-evoked increases in both erythrocyte velocity and
flux in the olfactory bulb [even after controlling for poten-
tially higher receptor activity after transporter blockade Petzold
et al. (2008)]. In contrast to experiments in the visual cortex
(Schummers et al., 2008) however, Petzold et al. (2008) observed
no significant change of the calcium response in astrocyte somata
when blocking glial glutamate uptake. While further experimen-
tation is needed to resolve the signaling molecules which underlie
this mechanism of CBF control, these data suggest that calcium-
independent vasodilatory pathways may exist. Indeed, IP3-
independent stimulation-induced vasodilation has recently been
observed in the cortex of IP3 knockout mice (Nizar et al., 2013).
The role of astrocyte Ca2+ signaling in the regulation of CBF is
currently hotly debated and will be discussed later in this review.
In contrast to brain slices, glutamate is largely ineffective in
evoking glial [Ca2+]i increases in the retina. In retina, neuron-
to-glia signaling, and resulting vasoactivity, is mediated by neu-
ronal release of ATP and activation of purinergic P2Y receptors
(Newman, 2005; Metea and Newman, 2006). Activation of P2Y
receptors (which are highly expressed in astrocyte endfeet: Simard
et al., 2003), activates phospholipase C (PLC) and the down-
stream calcium-dependent signaling pathways discussed above
(Figure 2). ATP can also act on glial P2X7 receptors, resulting
in an increase in astrocyte [Ca2+]i (Carrasquero et al., 2009;
Habbas et al., 2011) and triggering the formation and release
of vasoactive substances (Figure 2). In addition to neuronally
released ATP, calcium-dependent ATP exocytosis by glial cells may
occur (Pangrsic et al., 2007; Blum et al., 2008). ATP which is
released into the extracellular space is rapidly hydrolyzed to form
adenosine (Xu and Pelligrino, 2007) which has been shown to be
vasodilatory in both the cerebral cortex and cerebellum, and is
thought to be involved in functional hyperemia in vivo (Dirnagl
et al., 1994; Akgoren et al., 1997; Shi et al., 2008).
Increases in extracellular concentrations of K+ cause vasodi-
lation in cerebral arterioles (Kuschinsky and Wahl, 1978).
Although the original hypothesis of “astrocyte K+ siphoning”
(Paulson and Newman, 1987) has been disproved (Metea et al.,
2007), a calcium-dependent mechanism by which astrocytes
may contribute to the regulation of CBF via K+ has been
demonstrated (Filosa et al., 2006). BKCa channels in astrocyte
endfeet were shown to be activated following neuronal activity-
evoked increases in astrocytic [Ca2+]i via mGluR activation. The
resulting local increase in extracellular K+ activated Kir channels
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(Kir2.1) on the smooth muscle cell, hyperpolarizing the cell and
leading to vasodilation. This work is consistent with in vivo stud-
ies inhibiting BKCa channels (Gerrits et al., 2002) and Kir channels
(Leithner et al., 2010), both of which were found to result in an
attenuation of the CBF increase evoked by somatosensory acti-
vation. However, as glial membrane potentials are close to the
equilibrium potential for K+ (Kuffler et al., 1966), increasing K+
conductance may not result in an increased net efflux of K+.
Furthermore, as the contribution of endfeet K+ efflux (via glial
Kir4.1 channels) has been disproved in the retina (Metea et al.,
2007), its role in the cortex needs to be verified.
DO ASTROCYTES PLAY A ROLE IN THE REGULATION OF CBF
IN VIVO?
Several experimental models have been used to investigate the
role of astrocytes in the regulation of CBF in vivo including:
uncaging of Ca2+ within astrocytes, somatosensory stimulation,
pharmacological inhibition, and genetic deletion.
When Ca2+ was uncaged within astrocyte endfeet, triggering
an increase in astrocyte [Ca2+]i, dilation of an adjacent arteriole
was observed (Figures 1C,D) (Takano et al., 2006). In agreement
with the suggestion that AA conversion to PgE2 underlies the dila-
tion, inhibition of COX-1 but not COX-2 enzymes blocked the
vasodilations. However, controversy remains regarding the role of
COX-1 in neural activity-evoked vasodilation. While COX-1 inhi-
bition (with a high dose of SC560) can inhibit the CBF response
to odorant stimulation in the olfactory bulb (Petzold et al., 2008)
or uncaging of Ca2+ in astrocytes in the cortex (Takano et al.,
2006), lower doses of SC560 have no effect on the CBF response
to whisker stimulation (Niwa et al., 2001; Lecrux et al., 2011;
Liu et al., 2012). Furthermore, genetic deletion of COX-1 had no
effect on functional hyperemia (Niwa et al., 2001). In contrast,
pharmacological inhibition or genetic knockout of COX-2 atten-
uates the CBF response to neuronal activation (Niwa et al., 2000).
As COX-2 is more highly expressed in neurons than astrocytes,
these data have led to the suggestion that neuronal COX activ-
ity may underlie the component of functional hyperemia which
is mediated by COX products. Recent data suggests that photol-
ysis of caged Ca2+ might artifactually produce vasodilation via
glutamate-permeable anion channels. Activation of these chan-
nels (either by calcium or astrocytic volume changes following
photolysis) leads to glutamate release and an mGluR-mediated
increase in mEPSC frequency. Photolysis-induced astrocytic glu-
tamate release activates neuronal mGluRs and NMDA/AMPA
receptors resulting in K+ efflux and neuronal depolarization (and
potentially smooth muscle cell hyperpolarization due to increased
extracellular K+) (Wang et al., 2013). This effect may explain
the differing effects of COX-1 inhibition on sensory stimulus-
mediated vasodilation vs. photolysis-mediated vasodilation. In
addition, regional heterogeneity of COX-1 expression (as has
been found for nNOS) may offer a further explanation for the
differing effects of COX-1 inhibition which have been observed.
Although some groups have used sensory stimuli to investi-
gate the signaling pathways underlying astrocyte-mediated CBF
changes (e.g., Zonta et al., 2003; Petzold et al., 2008), much
of the evidence for astrocytic mGluR-mediated vasodilations is
based on in vitro work using tissue from juvenile rodents (e.g.,
Zonta et al., 2003; Mulligan and MacVicar, 2004). A role for
mGluR-mediated vasodilations in adult rodents remains con-
tentious. Recent research has suggested that expression levels
of mGluR5 alter with development, being undetectable beyond
postnatal week 3 (Sun et al., 2013). In agreement with this finding,
Calcinaghi et al. (2011), using a highly specific mGluR5 blocker,
found no evidence for a role of mGluR5 in the onset or mainte-
nance of CBF increases in the whisker barrel of adult anesthetized
rats in response to brief whisker stimulation. Furthermore, block-
ade of mGluRs in the olfactory bulb had no effect on the hemo-
dynamic response to odor stimulation (Gurden et al., 2006).
However, in contradiction to these results, mGluR5-antagonist
sensitive sensory simulation-evoked astrocyte [Ca2+]i transients
in the barrel cortex of adult mice have been reported (Wang
et al., 2006; Lind et al., 2013). In the olfactory bulb, Petzold et al.
(2008) reported that the mGluR5 antagonist, MPEP, decreased
vasodilations, supporting the idea that functional hyperemia is
mediated, at least in part, by mGluR5, which, within the glomeru-
lar layer is expressed exclusively in astrocytes. Vasodilations were
also reduced by inhibiting COX-1, suggesting that the functional
hyperemia mediated by astrocytic mGluR5 depends on COX-
1 activity. It remains unclear, therefore, under what conditions
mGluR5 plays a role in neurovascular coupling.
Several additional factors may explain the discrepencies
observed in different studies. Regional differences in expression
of mGluR5 and/or the importance of mGluR-mediated signal-
ing for the regulation of CBF may exist (MPEP reduces fMRI
responses to hindpaw stimulation in rat primary cortex by only
18%, compared to 66% in striatum: Sloan et al., 2010). mGluR5
may be upregulated in reactive astrocytes (Aronica et al., 2000),
suggesting that the role of astrocytic mGluR5 in neurovascular
coupling may be associated more with non-physiological condi-
tions. The recruitment of astrocyte calcium-mediated vasodila-
tion may depend upon the frequency of stimulation used. Wang
et al. (2006) demonstrated that astrocyte calcium signals in the
barrel cortex of mice were a function of frequency, with sig-
nals rarely evoked by a 1 Hz whisker stimulation and peaking
in response to 5Hz stimulation (although this may only occur
in the anesthetized state, see Thrane et al., 2012). Furthermore,
recent imaging of neuronal and astrocytic calcium signals in the
rat somatosensory cortex has shown that high frequency activa-
tion of the forepaw (a 10 Hz but not a 1 Hz stimulus) leads to a
late component of vasodilation that is correlated with increased
astrocyte calcium and increased CBF as measured by fMRI BOLD
signals (Schulz et al., 2012). The findings discussed throughout
this review suggest that there is a complex interaction of many
factors (both astrocytic and neuronal) determining how CBF is
controlled, both basally and in response to neural activity. The
task of studying the cellular functionality of astrocytes and/or
neurons is thus a challenging one.
In addition to the vasodilations described above, there is in
vivo evidence for astrocyte [Ca2+]i transients resulting in vaso-
constriction. Two-photon imaging of astrocytes bulk loaded with
calcium indicator dyes revealed that vasoconstrictions of pene-
trating cortical arterioles occurred during spreading depression
(SD) at the onset of the fast astrocytic Ca2+ wave (Chuquet
et al., 2007). Inhibiting either PLA2 or the refilling of internal
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calcium stores reduced the SD-induced vasoconstriction, sug-
gesting that astrocytes mediate SD-induced vasoconstrictions via
PLA2-mediated AA release.
In summary, the evidence suggests that in response to neu-
ral activity, astrocyte [Ca2+]i increases and vasoactive messengers
are released from astrocytic endfeet. Thus, astrocytes may evoke
changes in arteriole diameter and regulate CBF.
ARE ACTIVITY-EVOKED ASTROCYTE CALCIUM TRANSIENTS
WIDESPREAD AND FAST ENOUGH TO CONTRIBUTE TO
NEUROVASCULAR COUPLING?
Although a large body of evidence has been acquired over the past
decade suggesting that astrocytes are potential mediators of func-
tional hyperemia, the idea remains controversial. The presence,
prevalence, and timing of astrocyte Ca2+ signaling in response
to neural activity and its role in the regulation of CBF is cur-
rently hotly debated. In a recent review, Cauli and Hamel (2010)
discuss the relative timings of astrocytic and neuronal calcium
responses to neuronal activity. Rapid calcium events are thought
to reflect activation of ionotropic receptors (which are expressed
frequently in neurons), while slower calcium responses are pro-
posed to reflect activation of metabotropic receptors (expressed
by astrocytes and neurons) and the release of calcium from intra-
cellular stores. These calcium signal dynamics agree with the
observation that calcium events in neurons often precede those in
astrocytes (Wang et al., 2006; Schummers et al., 2008; Nizar et al.,
2013). These data would suggest that astrocytes may only con-
tribute to functional hyperemia in the late phase of the response.
Recent studies have suggested that arteriole dilations resulting
from neural activity may not only precede astrocytic [Ca2+]i sig-
nals (Nizar et al., 2013) but can, in fact, occur in the absence of
glial [Ca2+]i signals (Schulz et al., 2012).
Using in vivo 2-photon imaging of astrocytes, Wang
et al. (2006) reported whisker stimulation-evoked astrocyte
[Ca2+]i transients in the barrel cortex which peak several sec-
onds post stimulation. Such transients are too slow to trigger
the hemodynamic response to neural activity, which occurs any-
where from a few hundred milliseconds to a couple of seconds
after the onset of neuronal activity (Kleinfeld et al., 1998; Devor
et al., 2003; Zonta et al., 2003). This idea is supported by evi-
dence suggesting that there is a long lag time between the onset of
stimulation and astrocyte [Ca2+]i transients (Schulz et al., 2012;
Thrane et al., 2012) and that, following forepaw stimulation, the
onset of astrocyte calcium responses may lag behind the onset
of arteriole dilation at the same depth within the cortex (Nizar
et al., 2013). In this last study (as is common in such studies),
bulk loading of the calcium indicator dye, Oregon Green Bapta-
1 (OGB-1) was used to measure calcium signals in both neurons
and astrocytes. During data analysis the astrocyte region of inter-
est (ROI) was minimized in order to avoid contamination from
neuropil signals, which were suggested to account for the initial
rapid calcium transients sometimes observed within an astro-
cyte ROI. Such rapid transients were not observed in astrocytes
when using the calcium indicator dye Fluo-4, which was absent
in neurons. The difficulty in determining with 100% certainty
whether a calcium signal is within an astrocyte, astrocytic pro-
cess, or neuropil highlights the need for the development both
of improved sensitivity of 2-photon detection and of better dye
localization. However, other studies also using in vivo 2-photon
microscopy, IOS and bulk loading of calcium indicator dyes, con-
tradict these findings. Within the olfactory bulb glomerulus, odor
stimulation resulted in a local increase in CBF which was strongly
correlated, both spatially and temporally, with an increase in
astrocytic [Ca2+]i (Petzold et al., 2008). More recently, Lind et al.
(2013) used signal-enhancing analysis of Ca2+ activity to give
higher sensitivity to fast Ca2+ signals. This study demonstrates
that, in contrast to the small proportion of astrocytes previously
reported to exhibit fast [Ca2+]i transients (Winship et al., 2007),
in the whisker barrel cortex of adult mice 66% of astrocyte somata
and 70% of processes exhibit a stimulus-evoked [Ca2+]i eleva-
tion with rapid onset (peak ∼100 ms) and short duration which
precedes local vasodilations (Lind et al., 2013). While stimulus-
evoked [Ca2+]i transients occurring concurrently in neurons and
astrocytes correlated with synaptic activity, only the astrocytic sig-
nals correlated with hemodynamic changes. Astrocytic calcium
transients consisted of a fast response and, in ∼10% of astrocytes,
slow augmentation. The authors suggest that it is this slow com-
ponent that has been previously reported by other studies and
that it is their improved analysis method which enables the fast
component to be detected.
ARE SUBCELLULAR CA2+ TRANSIENTS IMPORTANT?
In brain slices, it has been shown that calcium signals can occur
in astrocytic processes in the absence of changes in the cell body
(Di Castro et al., 2011). It may be that subcellular astrocyte cal-
cium transients, e.g., those in the endfeet rather than those in
the soma, are important for the regulation of CBF (McCaslin
et al., 2011; Dunn et al., 2013; Lind et al., 2013). Devor’s group
reported that the onset of [Ca2+]i transients in endfeet (which
may precede those in the soma: Wang et al., 2006) were delayed
relative to the onset of arteriole dilation at the same cortical depth
(Nizar et al., 2013). However, Lind et al. (2013) demonstrated fast
[Ca2+]i transients within endfeet which preceeded local vasodi-
lation. In order to investigate [Ca2+]i transients in the astrocytic
soma and/or processes, these studies, along with those of other
groups (e.g., Dunn et al., 2013), utilized bulk loading of calcium
indicator dye which lacks cellular specificity. The development
of targeted expression of genetically induced calcium indicators
will allow better dye localization and may result in the reliable
detection of fast subcellular [Ca2+]i transients. Such subcellu-
lar transients could result in the release of vasoactive substances,
hence playing a role in the regulation of CBF. Although this tech-
nique has yet to reveal results in vivo, membrane-bound genetic
calcium indicators have been shown to detect local, subcellular,
calcium rises in cultured astrocytes (Shigetomi et al., 2010a,b).
Finally, the majority of published neurovascular coupling
studies have been performed in the cortex of anesthetized ani-
mals. Anesthetics may disrupt important features of neurovas-
cular coupling, thus acting as a confound in understanding
the cellular mechanisms underlying the regulation of CBF in
response to neural activity (Martin et al., 2012). Three commonly
used anesthetic combinations (ketamine/xylazine, isoflurane, and
urethane) have been found to significantly suppress sensory-
evoked astrocyte [Ca2+]i transients in mice (Thrane et al., 2012).
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Sensory-evoked [Ca2+]i transients were found to be more delayed
with a slower rise time and longer duration in anesthetized ani-
mals compared to awake animals (Thrane et al., 2012). Further
studies in awake rodents, such as those performed by Martin
et al. (2012), are required in order to fully investigate the role
of astrocytes, and their sensory-evoked [Ca2+]i transients, in
neurovascular coupling.
CONCLUSIONS
The work outlined here demonstrates that astrocytes are capa-
ble of eliciting both vasoconstriction and vasodilation of brain
arterioles. A popular hypothesis of astrocytic control of CBF in
response to neural activity has been that neuronally released glu-
tamate acts on astrocytic mGluRs to raise astrocytic [Ca2+]i,
initiating downstream production of AA and the formation and
release of vasoactive substances (Zonta et al., 2003; Mulligan
and MacVicar, 2004; Takano et al., 2006; Petzold et al., 2008).
However, recent studies have called into question the role of
mGluR5 and IP3-mediated downstream pathways in the func-
tional hyperemia response (Gurden et al., 2006; Calcinaghi et al.,
2011; Nizar et al., 2013; Sun et al., 2013). Evidence from the
retina suggests that neuron-glia signaling may be mediated by
neuronally released ATP acting on glial P2Y receptors rather than
via activation of mGluRs by glutamate (Newman, 2005; Metea
and Newman, 2006). Indeed, it has been shown that astrocyte
[Ca2+]i signals can be evoked by ATP in the cerebral cortex (Sun
et al., 2013) and in cerebellar slices (Piet and Jahr, 2007; Habbas
et al., 2011). Alternative hypotheses of astrocyte control of ves-
sel diameter also include the efflux of K+ through Ca2+-activated
K+ channels in astrocyte endfeet (Filosa et al., 2006), although
the functional, in vivo, significance of this pathway remains to
be demonstrated. The role of astrocyte [Ca2+]i transients in the
control of CBF in vivo during functional hyperemia remains con-
troversial. An inability to observe Ca2+ transients that are fast
enough for neurovascular coupling has called into question the
impact of astrocytes on CBF regulation in response to neural
activity (Nizar et al., 2013). Recent advances in data analysis
techniques resulting in a higher sensitivity to fast Ca2+ signals
may have overcome this problem (Lind et al., 2013), providing
direct evidence for the existence of Ca2+ responses which are
rapid enough to contribute to neurovascular coupling. It is, how-
ever, worth considering that while we study Ca2+ because we
can currently visualize it, Ca2+-independent mechanisms such
as those involving glutamate transport (Gurden et al., 2006;
Petzold et al., 2008; Schummers et al., 2008) may play an impor-
tant role in astrocyte-mediated regulation of CBF. A role for
astrocytes in the control of CBF in pathology also remains a pos-
sibility (Chuquet et al., 2007). While the evidence suggests that
astrocytes are important players in neurovascular coupling and
functional hyperemia, the questions of whether astrocytes play a
dominant role in triggering fast hemodynamic responses and, in
particular, under what circumstances astrocytic Ca2+-mediated
pathways are responsible, remain open. The exact mechanisms by
which astrocytes are able to sense changes in neuronal activity
and trigger the intracellular events regulating the resulting vas-
cular response which underlies the fMRI BOLD signal remain
unclear. Indeed, which pathway predominates may often result
from the experimental model used. Other issues which remain
to be solved are: what is the functional significance of astrocytic
[Ca2+]i transients in awake animals? Under what circumstances
are mGluR-mediated vasodilation and constriction important?
What are the messengers underlying neurovascular coupling in
healthy and diseased brain? Do slow astrocyte [Ca2+]i signals
contribute to the sustained hemodynamic response? Research
on this topic must continue. New technologies such as targeted
genetic encoding of calcium indicators, optogenetics, and trans-
genic mouse lines allowing astrocyte physiology specifically to
be altered will help us move forward with this research. Only
by fully understanding the cellular mechanisms underlying func-
tional hyperemia and the resulting BOLD signal will we be able to
accurately interpret the BOLD fMRI signal in health and disease.
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